While Health Canada, which provided an update on April 24th, continues to get the official data out to the public very slowly, the patient enrollment growth in the ACMPR...
The first week of trading for the new Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF) has been a tremendous success. While Tuesday saw its first decline...
With Canada set to make history this week by tabling legislation to make the nation the first G-7 country to legalize cannabis for adult use, many investors are focusing...
Exclusive Interview with Jason Zandberg of PI Financial With Canada’s Liberal Party prepared to table legislation to legalize cannabis for adult use next week, we checked in with Jason...
Let’s face it, when it comes to cannabis stocks, Canada continues to crush the United States, where federal illegality makes it more difficult to operate and to raise capital....
Cronos Re-Invests in Whistler as Part of Transformative Expansion TORONTO, March 9, 2017 /CNW/ – Cronos Group Inc. (TSXV: MJN) (OTC: PRMCF) (“Cronos Group” or the “Company”) owns a...
After a boom in the stock prices of Canadian licensed producers (LPs) in 2016 that left the average stock up more than 355%, the sector is performing very well...
PharmaCan Capital Announces $15 Million Bought Deal TORONTO, ONTARIO–(Marketwired – Feb. 14, 2017) – PharmaCan Capital Corp., doing business as Cronos Group (TSXV: MJN) (OTC: PRMCF) (“Cronos” or the...
Statement from Health Canada on the Testing of Cannabis for Medical Purposes for Unauthorized Pest Control Products OTTAWA, Feb. 7, 2017 /CNW/ – Recently, two licensed producers of cannabis...
Last week, James West of the Midas Letter published interviews of four CEOs of publicly-traded Canadian licensed producers, including Vic Neufeld of Aphria (TSXV: APH) (OTC: APHQF), Brent Zettl of...
Investment Bank Cowen and Company, which initiated coverage on the cannabis industry in September, is hosting a gathering of institutional investors in New York City on January 12th. Several...
Perhaps the biggest story of 2016 in the cannabis capital markets was the surge in prices and the amount of capital raised for the cannabis industry in Canada during...
Minister Hehr announces a new reimbursement policy for Cannabis for Medical Purposes VANCOUVER, Nov. 22, 2016 /CNW/ – The Honourable Kent Hehr, Minister of Veterans Affairs and Associate Minister of...
PharmaCan Announces Corporate Rebranding to Become Cronos Group TORONTO, ON–(Marketwired – October 06, 2016) – PharmaCan Capital (TSXV: MJN) (“the Company”) today announced a corporate rebranding to Cronos Group....
Following up on its July announcement that it would be buying Peace Naturals, PharmaCan Capital (TSXV: MJN) (OTC: PRMCF) announced today that the deal has closed, creating the first licensed producer (LP)...
When Justin Trudeau and the Liberal Party won a majority of seats in the Canadian Parliament elections in October last year, it set off a quick pop in the...
PharmaCan Capital (TSXV: MJN) (OTC: PRMCF) announced that it will acquire Peace Naturals Project in a deal that is expected to close by the end of Q3. The company will be...
Despite a rapidly growing underlying industry, investors in the publicly-traded cannabis stocks have been dodging landmines for several years now, with few companies producing solid returns so far and...
Co-founder, President and CEO Paul Rosen has resigned from PharmaCan Capital (TSXV:MJN). Rosen, a pioneer in the Canadian cannabis industry, created a merchant bank to invest in the industry...
Alan Brochstein published an article on the publicly-traded Canadian cannabis stocks, including Aphria, Aurora Cannabis, Canopy Growth, Emerald Health, Mettrum, OrganiGram, PharmaCan Capital and Supreme Pharma. The article, which is...
Alan Brochstein, CFA, discussed the “State of the Legal Canadian Cannabis Industry” at the eMoneyShow Virtual Conference on 10/30/15: One of the biggest barriers to investing in cannabis companies is that...
